Refractory to Standard Therapies
1 clinical trials · Condition
◉ Watch Refractory to Standard Therapies
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study With Sorafenib and Sirolimus (NCT00509613) | Radboud University Medical Center | 2007-06-01 |
Track Refractory to Standard Therapies automatically
Every clearance here is in the API, with alerts when new ones post.